In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
73 News Items found
Kenneth Offit and Vijai Joseph
Finding
Making an IMPACT: MSK’s Gene-Sequencing Test Reveals New Findings about Hereditary Cancer Risk

An analysis of germline DNA in people with advanced cancer finds that inherited mutations may be more common than expected in this group.
Close-up of hand holding glass of red wine.
Does Drinking Alcohol Cause Cancer? Learn About the Risks

Learn more about the link between drinking alcohol and the risk of developing cancer.
Seen are Scott Stuart, MSK Chair, Board of Trustees, and Selwyn M. Vickers, MD, FACS, President and CEO of MSK
A Message From MSK Leaders Selwyn M. Vickers and Scott Stuart

The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report.
A women sitting in a chair holding a bell
Top Cancer Treatment Advances at MSK in 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.
Woman in field with dog dressed as tiger
A Surgical Milestone To Protect Fertility in Young People With Cancer

MSK surgeons do an innovative procedure called a uterine transposition — the first performed in the U.S. — to preserve a woman’s fertility during cancer treatment.
To our Community
A Message From Dr. Selwyn Vickers, MSK’s President and CEO

Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
MSK surgeon-scientist Vinod Balachandran.
Article
Cancer Researchers Shed Light on How Tertiary Lymphoid Structures Form

Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Elizabeth Cruz
8 Questions with Elizabeth Cruz, MSK Nurse

Elizabeth Cruz has been a nurse at Memorial Sloan Kettering for more than ten years. Learn more about what drives her.
MSK computational biologist Henry Walch
Why Is Colorectal Cancer in African Americans Hard To Treat? One Reason Is Genetics

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.
Gloved hands hold a pipette over two bottles of pink solution.
Finding
The Gut Microbiome and Cancer: MSK Researchers Present New Findings

Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.